Drug makers gain on accelerated FDA approval for a cervical cancer treatment.

Pieris and Seagen have amended an ongoing collaboration which will have the latter give the former $13 million in an equity investment as the two work together to study a gastric cancer drug.

These stocks that fell this past week could be 'buy the dip' opportunities. Recent losers include Seagen, Penn National, Palantir, Canopy Growth, Pepsi and more.

Stock futures rise as Wall Street debates tame inflation data; Bumble IPO raises $2.15 billion; Disney and Pepsi report earnings; Tilray surges again as cannabis sector is targeted by Reddit crowd.

The worst-performing stocks in the Nasdaq on Wednesday included Moderna, Seattle Genetics, and Facebook, among others.

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.